Optimizing Care for Challenging People Living With HIV
Launched by KAOHSIUNG MEDICAL UNIVERSITY CHUNG-HO MEMORIAL HOSPITAL · Dec 14, 2023
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is an intervention strategy for HIV-infected individuals based on their viral load measurements and medication adherence rates, measured by the proportion of days covered (PDC) for the past 365 days. A specific PDC threshold identifies individuals with less than 90% viral suppression at under 200 copies/mL. An intervention approach integrating social and behavioral models with electronic health (eHealth) technology is implemented for cases with a PDC below this threshold. The intervention aims to enhance the patient's adherence to their medication regimen. The effectiveness of this int...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. PLWH with adherence below the specific proportion of days covered (PDC), which is defined as the specific level that corresponds to 90% at viral suppression (\< 200 copies/mL).
- Exclusion Criteria:
- • 1. Under 18 years of age.
- • 2. Illiterate.
- • 3. Non-consenting individuals.
- • 4. Less than 365 days from the initial use of antiretroviral drugs to the assessment for inclusion in the study.
- • 5. Inability to obtain complete medication records for the 365 days prior to inclusion.
- • 6. Lack of a smart phone.
- • 7. No willingness to return for follow-up at the participating hospital.
About Kaohsiung Medical University Chung Ho Memorial Hospital
Kaohsiung Medical University Chung-Ho Memorial Hospital is a leading healthcare institution in Taiwan, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor, the hospital leverages its extensive expertise in various medical disciplines, state-of-the-art facilities, and a multidisciplinary team of professionals to conduct rigorous clinical studies. Committed to ethical standards and patient safety, the hospital collaborates with academic institutions and industry partners to facilitate groundbreaking research that contributes to the global medical community and enhances treatment options for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kaohsiung City, , Taiwan
Patients applied
Trial Officials
Chun-Yuan Lee, M.D.
Principal Investigator
Kaohsiung Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported